214 related articles for article (PubMed ID: 10713444)
21. Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3'-untranslated region. Possible role of redox-sensitive protein binding in mRNA accumulation.
Goswami PC; Sheren J; Albee LD; Parsian A; Sim JE; Ridnour LA; Higashikubo R; Gius D; Hunt CR; Spitz DR
J Biol Chem; 2000 Dec; 275(49):38384-92. PubMed ID: 10986283
[TBL] [Abstract][Full Text] [Related]
22. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
[TBL] [Abstract][Full Text] [Related]
23. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
Mo YY; Beck WT
Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the 3' untranslated region of mouse DNA topoisomerase IIalpha mRNA.
Kobayashi M; Adachi N; Koyama H
Gene; 1998 Jul; 215(2):329-37. PubMed ID: 9714832
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.
Jin S; Scotto KW
Mol Cell Biol; 1998 Jul; 18(7):4377-84. PubMed ID: 9632821
[TBL] [Abstract][Full Text] [Related]
26. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
Singh R; Winn LM
Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
[TBL] [Abstract][Full Text] [Related]
27. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
29. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
[TBL] [Abstract][Full Text] [Related]
30. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
32. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
33. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
34. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis.
Agostinho M; Rino J; Braga J; Ferreira F; Steffensen S; Ferreira J
Mol Biol Cell; 2004 May; 15(5):2388-400. PubMed ID: 14978217
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
Kotecha M; Kluza J; Wells G; O'Hare CC; Forni C; Mantovani R; Howard PW; Morris P; Thurston DE; Hartley JA; Hochhauser D
Mol Cancer Ther; 2008 May; 7(5):1319-28. PubMed ID: 18483319
[TBL] [Abstract][Full Text] [Related]
37. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
39. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.
Caretti G; Salsi V; Vecchi C; Imbriano C; Mantovani R
J Biol Chem; 2003 Aug; 278(33):30435-40. PubMed ID: 12771133
[TBL] [Abstract][Full Text] [Related]
40. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.
Sandri MI; Isaacs RJ; Ongkeko WM; Harris AL; Hickson ID; Broggini M; Vikhanskaya F
Nucleic Acids Res; 1996 Nov; 24(22):4464-70. PubMed ID: 8948636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
